Similar Papers

Paper Title
Journal
Date
Author
OAB-020: The role of checkpoint inhibitor PD-1H/VISTA in Multiple Myeloma bone disease
Jing Fu ... Suzanne Lentzsch
Clinical Lymphoma Myeloma and Leukemia | VOL. 21
Jing Fu, et. al.Jing Fu ... Suzanne Lentzsch
01 Oct 2021
Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not
Shoso Munemasa ... Hideki Asaoku
British Journal of Haematology | VOL. 139
Shoso Munemasa, et. al.Shoso Munemasa ... Hideki Asaoku
11 Sep 2007
IL3 Induces Osteoclastogenesis In Vivo and Is Modulated By Bone Marrow Monocyte / Macrophage Derived Activin A
Rebecca Silbermann ... Nicola Giuliani
Blood | VOL. 122
Rebecca Silbermann, et. al.Rebecca Silbermann ... Nicola Giuliani
15 Nov 2013
Bone Metabolism of Multiple Myeloma Bone Disease Patients with Different Blood Separation Results
Ze-Wen Fan ... Jing-Yu Zhang
Zhongguo shi yan xue ye xue za zhi | VOL. 32
Ze-Wen Fan, et. al.Ze-Wen Fan ... Jing-Yu Zhang
01 Jun 2024
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence
Simone Seyringer ... Eva M Gamper
European Journal of Cancer | VOL. -
Simone Seyringer, et. al.Simone Seyringer ... Eva M Gamper
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama ... Salvatore Provenzano
European Journal of Cancer | VOL. -
Annalisa Trama, et. al.Annalisa Trama ... Salvatore Provenzano
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.